Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: A new pro-atherogenic mechanism of hypertension

Cardiovascular Research

Volumn 78, Issue 3, 2008, Pages 581-589

  Sendra, Judith ^a   Llorente Cortés, Vicenta ^a   Costales, Paula ^a   Huesca Gómez, Claudia ^a   Badimon, Lina ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Aggregated LDL; Angiotensin II; Arteriosclerosis; AT1 receptors; LRP1; Vascular smooth muscle cells

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CHOLESTEROL ESTER; LACTOFERRIN; LIPID; LOSARTAN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA; ARTICLE; ATHEROGENESIS; BLOOD VESSEL WALL; CONTROLLED STUDY; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; LIPID BLOOD LEVEL; LIPID STORAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ATHEROSCLEROSIS; CELLS, CULTURED; CHOLESTEROL ESTERS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; IMIDAZOLES; LACTOFERRIN; LDL-RECEPTOR RELATED PROTEIN 1; LOSARTAN; MALE; MUSCLE, SMOOTH, VASCULAR; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; UP-REGULATION;

EID: 44449161962     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn043     Document Type: Article

References (32)

1. Prasad A, Quyyumi AA. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation 2004;110: 1507-1512.
2. Nickening G. Central role of the AT1-receptor in atherosclerosis. J Human Hypertens 2002;16:S26-S33.
3. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB et al. Collaborative Study Group: renoprotective effect of the angiotensinreceptor antagonist irbersartan in patients with nephropathy due to type II diabetes. N Engl J Med 2001;345:851-860.
4. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-153.
5. Strawn WB, Ferrario C. Mechanisms linking angiotensin II and atherogenesis. Curr Opin Lipidol 2002;13:505-512.
6. Kintscher U, Lyon CJ, Law RE. Angiotensin II, PPAR-Gamma and Atherosclerosis. Front Biosci 2004;9:359-369.
7. Rosenson RS. Modulating atherosclerosis through inhibition or blockade of angiotensin. Clin Cardiol 2003;26:305-311.
8. Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 2005;118:939-947.
9. Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF et al. Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis 2006; 184:312-321.
10. Hiltunen TP, Luoma JS, Nikkari T, Yla-Herttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 1998;97:1079-1086.
11. Moestrup SK, Gliemann J, Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 1992;269:375-382.
12. Luoma J, Hiltunen T, Särkioja T, Moestrup SK, Gliemann J, Kodama Tet al. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest 1994;93:2014-2021.
13. Llorente-Cortés V, Otero-Viñas M, Berrozpe M, Badimon L. Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries. Eur J Clin Invest 2004;34:182-190.
14. Llorente-Cortés V, Otero-Viñas M, Sánchez S, Rodriguez C, Badimon L. Low density lipoprotein up-regulates low density lipoprotein receptorrelated protein expression in vascular smooth muscle cells. Possible involvement of sterol regulatory element binding protein-2-dependent mechanism. Circulation 2002;106:31104-31110.
15. Llorente-Cortés V, Otero-Viñas M, Camino-López S, Llampayas O, Badimon L. Aggregated low density lipoprotein uptake induces tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 2004;110:452-459.
16. Camino-López S, Llorente-Cortés V, Sendra J, Badimon L. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells. Cardiovasc Res 2008;73:208-216.
17. Llorente-Cortés V, Badimon L. LDL receptor-related protein and the Vascular Wall. Arterioscler Thromb Vasc Biol 2005;25:497-504.
18. Otero-Viñas M, Llorente-Cortés V, Peña E, Padro T, Badimon L. Aggregated low lipoproteins decrease metalloproteinase-9 expression and activity in human coronary smooth muscle cells. Atherosclerosis 2007; 194:326-333.
19. Willnow TE, Goldstein JL, Orth K, Brown MS, Herz J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem 1992;267:26172-26180.
20. Mahley RW, Ji ZS, Brecht WJ, Miranda RD, He D. Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism. Ann N Y Acad Sci 1994;737:39-52.
21. Llorente-Cortés V, Otero-Viñas M, Hurt-Camejo E, Martinez-González J, Badimon L. Human coronary smooth muscle cells internalize versicanmodi .ed LDL through LDL receptor-related protein and LDL receptors. Arterioscler Thromb Vasc Biol 2002;22:387-393.
22. Llorente-Cortés V, Royo T, Juan-Babot O, Badimon L. Adipocyte differentiation-related protein is induced by LRP1-mediated aggregated LDL internalization in human vascular smooth muscle cells and macrophages. J Lipid Res 2007;48:2133-2140.
23. LLorente-Cortés V, Otero-Viñas M, Camino-López S, Costales P, Badimon L. Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2006;26:117-123.
24. Nakamura A, Iwao H, Fukui K, Kimura S, Tamaki T, Nakanishi S et al. Regulation of liver angiotensinogen kidney renin mRNA levels by angiotensin II. Am J Physiol 1990;258:E1-E6.
25. Brasier AR, Jamaluddin M, Han Y, Patterson C, Runge MS. Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor. Mol Cell Biochem 2000;212:155-169.
26. Strawn WB, Chappell MC, Dean RH, Kivlighn S, Ferrario CM. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000;101:1586-1593.
27. Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004;110:3062-3067.
28. Limor R, Kaplan M, Sawamura T, Sharon O, Keidar S, Weisinger G et al. Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway. Am J Hypertension 2005;18:299-307.
29. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000;105:1605-1612.
30. Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001;103:448-454.
31. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen KS, Nordestgaard BG. Increased transvascular lipoprotein transport in diabetes: association with albuminuria and systolic hypertension. J Clin Endocrinol Metab 2005;90:4441-4445.
32. Boucher P, Gotthardt M, Li W-P, Anderson RG, Herz J. LRP: role in vascular wall integrity protection from atherosclerosis. Science 2003;300: 329-332.